Salivary proteins provide
valuable information
The protein picture or proteome of saliva is complex and susceptible to many physiologic and biochemical changes. Protein biosynthesis begins in the salivary glands, and changes to the proteins take place in the mouth after secretion until leaving the oral cavity by swallowing. Changes are observed on four levels, beginning in the salivary glands with basic biosysthesis from the genetic blueprint. Second, there are changes within the protein cells prior to secretion into the mouth. Third, changes occur during secretion and transit through the ductal tree. The final stage of modifications happens after the proteins enter the non-sterile oral cavity and mix with gingival crevicular fluid, bacteria, desquamated epithelial cells and neutrophils.
Several changes take place prior to secretion of saliva from the salivary glands, including glycosylation (the addition of a carbohydrate molecule), phosphorylation (adding a phosphate group) and proteolysis (breakdown of proteins into simpler molecules). These changes produce closely related families of molecules. These changes influence the predisposition of some individuals for colonization of specific bacterial species that will be helpful as a diagnostic tool. Phosphorylation is important to the balance of minerals and the precipitation of substances onto enamel surfaces.
Saliva leaves the salivary glands under neurological control, depending on a stimulus. The amount and type of proteins contained in saliva will depend on the neurological stimulus provided.
Clinical Implications: Salivary proteins play an important role in the identification of biomarkers for oral and systemic diseases. Learning more about them will provide diagnostic information for the future.
Helmerhorst, E., Oppenheim, F.: Saliva: A Dynamic Proteome. J Dent Research 86: 680-693, 2007.
|
Photodynamic options for
treating periodontitis
Use of a photoactive dye activated by a cold laser of a specific light spectrum in the presence of oxygen is called photodynamic therapy (PDT). This technology has been used for many years to treat and control oral lesions, head and neck cancer, and other malignancies. It is used to treat macular degeneration, bladder cancer, and gynecologic tumors. It is also used to treat periodontal disease (PerioWave available in Canada and soon in the United States). Studies underway currently include treatments for cancers of the brain, breast, skin, prostate, cervix, pancreas, and other organs.
PDT works by damaging cells, cell membranes and cell contents. Illumination of the photoactive dye leads to changes in the calcium and lipid metabolism within cells, producing cytokines and stress hormones. The diode laser is easy to use, portable and cost-effective. In the past, a variety of light sources have been used: argon, Nd/YAG, and gold and copper vapor pumps. To treat larger areas, tungsten filament, quartz halogen, xenon arc, metal halide and phosphor-coated sodium lamps have been used. More recently, light-emitting diodes (LED) have been used for this treatment, as they are less expensive, small, lightweight and flexible.
Besides the bacteria and other organisms, the polysaccharides that make up the slime surrounding
bacteria in a biofilm are susceptible to the photodamage. This makes PDT therapy more desirable than antibiotics for control of biofilms around teeth, implants and associated with endodontically involved teeth. PDT is also effective against opportunistic infections like candidiasis and oral cancer.
Clinical Implications: Photodynamic therapy provides a new opportunity to treat periodontal disease and other oral lesions with a non-invasive, non-antibiotic approach.
Konopka, K., Goslinski, T: Photodynamic Therapy in Dentistry. J Dent Research 86: 694-707, 2007.
|